MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib in acute myeloid leukemia (AML) and other hematologic cancers.

Baxter to restart high-throughput IV solutions manufacturing line

Dive Brief: Baxter plans to restart its highest throughput manufacturing line for IV solutions within the next week, “barring any unanticipated developments,” the company said

October 25, 2024

Former FDA head Gottlieb calls for less regulation of certain AI tools

Dive Brief: Scott Gottlieb, the Food and Drug Administration commissioner during the first Trump administration, called for the agency to return to older policies on

February 11, 2025

Stretching vs. meditation: New study finds both practices reduce nocturnal muscle cramps in cirrhosis patients

Researchers investigate the effects of stretching and meditation on nocturnal muscle cramps in patients with cirrhosis.

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.